Tag: global open angle glaucoma oag market

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Open-Angle Glaucoma (OAG) Market By 2029?

The open-angle glaucoma (oag) market size has experienced significant expansion in recent years. It is projected to increase from $6.13 billion in 2024 to $6.53 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.5%. The growth observed in the past can be linked to the increasing occurrence of glaucoma among older demographics, heightened awareness regarding the early detection of eye conditions, rising expenditure on healthcare, government programs for vision care, and the worldwide proliferation of ophthalmology practices.

The market for open-angle glaucoma (oag) is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $8.36 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.4%. The predicted growth during this period can be attributed to several factors, including a growing demand for combination therapies, an increasing emphasis on personalized medicine, enhanced reimbursement policies for glaucoma treatments, a rising occurrence of lifestyle-induced ocular conditions, and an escalating need for non-invasive diagnostic approaches. Key trends identified for the forecast timeframe encompass the expanding adoption of AI in glaucoma diagnostics, a move towards outpatient glaucoma surgical interventions, the greater utilization of sustained-release glaucoma implants, increasing incorporation of wearable technology for monitoring intraocular pressure, and an intensified focus on sustainability within medical device production.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

What Are The Top Growth Drivers Impacting The Open-Angle Glaucoma (OAG) Market Outlook?

The increasing recognition of eye conditions is set to stimulate the expansion of the open-angle glaucoma (OAG) market. Eye illnesses encompass medical conditions affecting the structure, function, or vision of the eyes, ranging from minor issues like dry eye to serious diseases such as glaucoma and macular degeneration. Their prevalence is on the rise due to factors including aging populations, extended screen time, a surge in diabetes cases, environmental pollution, and lifestyle habits that compromise eye health. Open-angle glaucoma (OAG), a leading cause of blindness, particularly among older adults, emphasizes the crucial need for routine eye exams, early diagnosis, and proactive treatment to protect against irreversible vision loss. For instance, in October 2023, the Royal National Institute of Blind People (RNIB), a UK-based sight loss charity, reported that eye care outpatient appointments in the UK exceeded eight million in 2021/22, making it the most demanded specialty. Moreover, the number of individuals with sight loss, currently surpassing two million, is projected to double to over four million by 2050. Thus, the growing awareness of eye illnesses is driving growth in the open-angle glaucoma (OAG) market.

Which Key Segments Fueling The Open-Angle Glaucoma (OAG) Market?

The open-angle glaucoma (oag)market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma; Angle Closure Glaucoma; Other Disease Type

2) By Drug Class: Prostaglandin Analog; Beta Blockers; Adrenergic Agonist; Carbonic Anhydrase Inhibitors; Others Drug Class

3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users

4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG); Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma; Chronic Angle-Closure Glaucoma

3) By Other Disease Type: Normal-Tension Glaucoma; Congenital Glaucoma; Secondary Glaucoma

What Are The Latest Industry Trends Transforming The Open-Angle Glaucoma (OAG) Market?

Leading companies in the open-angle glaucoma (OAG) market are prioritizing the development of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to provide advanced and less intrusive options for managing primary open-angle glaucoma while reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) refers to a variety of surgical implants and techniques designed to lower intraocular pressure in glaucoma patients through small incisions and minimal disruption of ocular tissues. For instance, in December 2023, iSTAR Medical, a Belgium-based medtech company, launched MINIject in the Netherlands. This bio-integrating treatment for primary open-angle glaucoma utilizes a unique porous STAR material to enhance fluid outflow and reduce IOP. By decreasing dependency on conventional therapies, MINIject represents a significant breakthrough in glaucoma care, offering a safer and more effective management option for this leading cause of permanent blindness.

Which Key Players Are Driving Competition In The Open-Angle Glaucoma (OAG) Market?

Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Which Region Currently Holds The Largest Share Of The Open-Angle Glaucoma (OAG) Market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Open-Angle Glaucoma (OAG) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2025, By The Business Research Company

Antiglaucoma Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antiglaucoma-drugs-global-market-report

Glaucoma Surgery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report

Myopia And Presbyopia Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/myopia-and-presbyopia-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Open-Angle Glaucoma (OAG) Market Size from 2025 to 2034?

In recent times, the market size for open-angle glaucoma (oag) has experienced significant growth. It is projected to increase from $6.13 billion in 2024 to $6.53 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.5%. This growth during the historic period can be credited to the rising cases of glaucoma among older age groups, heightened awareness regarding early diagnosis of eye disorders, increasing healthcare spending, government-driven vision care initiatives, and the worldwide expansion of ophthalmology practices.

Predictions indicate a robust expansion for the open-angle glaucoma (oag) market in the upcoming years, with an anticipated growth to$8.36 billion in 2029″, escalating at a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this progression in the forecast range includes a burgeoning demand for combination treatments, a pivot towards personalised medication, enhanced reimbursement schemes for glaucoma procedures, a surge in ocular diseases induced by lifestyle changes, and an escalating requirement for non-invasive diagnostic techniques. Notable trends forecasted for this period encompass a growing inclination towards AI in glaucoma diagnostics, a transition towards outpatient glaucoma surgery, increased utilisation of sustained-release glaucoma implants, a rise in implementing wearable technology for measuring intraocular pressure, and an intensified focus on sustainable practices in the production of medical devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

What Are the Core Growth Drivers Propelling the Open-Angle Glaucoma (OAG) Market Forward?

The increasing understanding of eye diseases is anticipated to drive the expansion of the open-angle glaucoma (OAG) market in the future. Eye ailments refer to medical situations affecting the vision or functioning of the eyes, and can range from minor issues like dry eyes to severe conditions like glaucoma and macular degeneration. The rise in these medical situations stems from aging populations, extended screen times, a surge in diabetes cases, environmental contamination, and lifestyle practices that affect eyes. Open-angle glaucoma (OAG), a main source of blindness particularly in older adults, stresses the essential need for regular eye check-ups, early detection, and timely intervention to avert irreversible loss of sight. For example, as reported by the Royal National Institute of Blind People (RNIB), a UK-based charity for sight loss, the UK recorded over eight million eye care outpatient visits in 2021/22, marking it as the most sought-after specialty. Furthermore, the number of people with vision loss, presently over two million, is forecasted to jump to over four million by 2050. As a result, the escalating knowledge of eye ailments is propelling the growth of the open-angle glaucoma (OAG) market.

What Segment Types Define the Open-Angle Glaucoma (OAG) Market Structure?

The open-angle glaucoma (oag)market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma; Angle Closure Glaucoma; Other Disease Type

2) By Drug Class: Prostaglandin Analog; Beta Blockers; Adrenergic Agonist; Carbonic Anhydrase Inhibitors; Others Drug Class

3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users

4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG); Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma; Chronic Angle-Closure Glaucoma

3) By Other Disease Type: Normal-Tension Glaucoma; Congenital Glaucoma; Secondary Glaucoma

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Open-Angle Glaucoma (OAG) Market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing theOpen-Angle Glaucoma (OAG) Industry Evolution?

The prominent firms in the open-angle glaucoma (OAG) market are focusing on the advancement of cutting-edge solutions such as minimally invasive glaucoma devices (MIGDs). These novel solutions are aimed to offer better and lesser invasive substitutes for managing primary open-angle glaucoma, thereby mitigating the overreliance on conventional methods. A minimally invasive glaucoma device (MIGD) is an assortment of medical implants and practices developed to reduce the intraocular pressure in patients suffering from glaucoma, achieved via minimal incisions and least disturbance to the ocular tissues. For example, iSTAR Medical, a medical tech company headquartered in Belgium, introduced MINIject in the Netherlands in December 2023. This integrated therapy for primary open-angle glaucoma employs an exclusive porous STAR material to improve fluid drainage and lessen intraocular pressure (IOP). By lessening dependability on traditional treatments, MINIject brings a significant leap forward in the treatment of glaucoma, presenting a safer and more effective control solution for this primary contributor to irreversible blindness.

View the full report here:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

What Is the Definition of the Open-Angle Glaucoma (OAG) Market?

Open-angle glaucoma (OAG) is a chronic, progressive eye condition characterized by the gradual clogging of the drainage canals in the eye, leading to increased intraocular pressure that damages the optic nerve, often without noticeable symptoms until significant vision loss occurs. Its treatment aims to lower intraocular pressure, thereby preventing optic nerve damage and preserving vision through medications, laser procedures, or surgical interventions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20911

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Open-Angle Glaucoma (OAG) Market?

The market for open-angle glaucoma (OAG) has been showing robust growth in recent years. The current market worth of $6.13 billion in 2024 is expected to increase to $6.55 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this growth during the historical period include a higher occurrence rate of glaucoma in aging demographics, increased consciousness about early screening for eye diseases, escalated healthcare spending, government-led vision care programs, and the worldwide growth of ophthalmology practices.

What Growth Rate Is Forecasted for the Open-Angle Glaucoma (OAG) Market by 2029?

Strong expansion is anticipated in the open-angle glaucoma (OAG) market over the coming years, with the size predicted to reach $8.42 billion in 2029, boasting a compound annual growth rate (CAGR) of 6.5%. This growth during the prediction period can be associated with growing demands for combination therapies and a heightened interest in personalized medicine. It can also be attributed to refined reimbursement policies for glaucoma treatments, augmented incidence of lifestyle-related eye conditions, and an escalating demand for non-invasive diagnostic methods. The predicted period also sees key trends such as increased employment of AI in glaucoma diagnostics, a move towards outpatient glaucoma surgical procedures, a growing utilization of sustained-release glaucoma implants, increased incorporation of wearable technology for tracking intraocular pressure, and an enhanced focus on sustainability in the production of medical devices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

Which Key Companies Are Shaping the Future of the Open-Angle Glaucoma (OAG) Market?

Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals

Which Factors Are Driving Demand in the Open-Angle Glaucoma (OAG) Industry?

As people become more conscious of eye diseases, it is anticipated that this will stimulate growth in the open-angle glaucoma (OAG) market. Eye diseases refer to a broad spectrum of conditions affecting the eyes’ structure, functionality, or vision, spanning from trivial issues like dry eye to severe ailments such as glaucoma and macular degeneration. Factors such as an aging demographic, extended screen time, rising diabetes cases, environmental pollution, and lifestyle practices that stress eye health contribute to an increase in their occurrence. Open-angle glaucoma (OAG), a main cause of blindness primarily in the elderly, emphasizes the essentiality of regular eye check-ups, early detection, and aggressive treatment to avoid irreversible vision impairment. For example, the Royal National Institute of Blind People (RNIB), a sight loss charity located in the UK, reported in October 2023 that the number of eye care outpatient visits in the UK surpassed eight million in 2021/22, making it the most sought-after specialty. In addition, it is anticipated that the current figure of over two million people suffering from sight loss will likely double to more than four million by 2050. As such, the escalating consciousness about eye diseases is facilitating growth in the open-angle glaucoma (OAG) market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

How Is the Open-Angle Glaucoma (OAG) Market Segmented by Several Divisions?

The open-angle glaucoma (OAG) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

What are the Emerging Market Trends Driving the Growth of the Open-Angle Glaucoma (OAG) Industry?

Top-rated companies in the open-angle glaucoma (OAG) market are focusing on the creation of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to offer cutting-edge, less invasive options for managing primary open-angle glaucoma, moving away from traditional treatment methods. A minimally invasive glaucoma device (MIGD) is a variety of surgical implants and methods developed to reduce intraocular pressure in patients with glaucoma via tiny incisions and minimal disruption to ocular tissues. For example, in December 2023, MINIject was launched in the Netherlands by iSTAR Medical, a Belgium-based medical technology company. This integrated treatment for primary open-angle glaucoma uses porous STAR material to improve fluid outflow and lower IOP. MINIject marks a considerable advancement in glaucoma treatment by providing a safer and more effective management method for this main reason for irreversible blindness, reducing reliance on traditional therapies.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Which Regions Are Driving Growth in the Open-Angle Glaucoma (OAG) Market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20911

This Report Delivers Insight On:

1. How big is the open-angle glaucoma (oag) market, and how is it changing globally?

2. Who are the major companies in the open-angle glaucoma (oag) market, and how are they performing?

3. What are the key opportunities and risks in the open-angle glaucoma (oag) market right now?

4. Which products or customer segments are growing the most in the open-angle glaucoma (oag) market?

5. What factors are helping or slowing down the growth of the open-angle glaucoma (oag) market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Has The Open-Angle Glaucoma (OAG) Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In recent times, there has been considerable expansion in the open-angle glaucoma (OAG) market. We anticipate growth from $6.13 billion in 2024 to $6.55 billion in 2025, marking a compound annual growth rate (CAGR) of 6.8%. This upswing during the historical period can be traced back to factors such as an upsurge in glaucoma cases in elderly populations, heightened consciousness about the early diagnosis of ocular diseases, escalated spending on healthcare, implementation of vision care schemes by governments, and augmented global ophthalmology operations.

The market size for open-angle glaucoma (OAG) is projected to experience a significant rise in the coming years, soaring to a value of $8.42 billion in 2029, with a compound annual growth rate (CAGR) of 6.5%. The augmentation observed in the forecast period is due to a surge in demand for combination therapies, an increased emphasis on personalized medicine, better reimbursement policies for glaucoma treatments, an escalating frequency of lifestyle-induced ocular conditions, and a rising preference for non-invasive diagnostic techniques. Over that forecast period, major movements are expected to be seen, such as the increased utilization of AI in glaucoma diagnostics, a switch towards outpatient glaucoma surgical procedures, higher usage of sustained-release glaucoma implants, greater integration of wearable technology for monitoring intraocular pressure, and an enhanced focus on sustainability within medical device production.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Open-Angle Glaucoma (OAG) Market?

The escalating cognizance of eye maladies is anticipated to stimulate the advancement of the open-angle glaucoma (OAG) market in the future. Eye maladies involve health issues affecting the anatomy, functionality, or sight of the eyes, varying from minor troubles like dry eye to severe ailments like glaucoma and macular degeneration. They are becoming more prevalent due to the aging population, extended screen usage, growing incidences of diabetes, environmental contamination, and lifestyle choices that put eye health at risk. Open-angle glaucoma (OAG), a main cause of vision loss, particularly in older individuals, highlights the important need for regular eye check-ups, prompt identification, and proactive management to prevent permanent loss of vision. For instance, the Royal National Institute of Blind People (RNIB), a sight loss charity based in the UK, reported in October 2023 that eye care outpatient appointments in the UK topped eight million in 2021/22, positioning it as the most sought-after specialty. In addition, the count of individuals experiencing sight loss, which currently exceeds two million, is expected to surge to over four million by 2050. Thus, the escalating cognizance of eye maladies is fuelling growth in the open-angle glaucoma (OAG) market.

Which Key Market Segments Comprise the Open-Angle Glaucoma (OAG) Market and Drive Its Revenue Growth?

The open-angle glaucoma (OAG) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

Which Areas Are Leading Regions in the Open-Angle Glaucoma (OAG) Market Expansion Across the Globe?

North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Open-Angle Glaucoma (OAG) Industry?

Leading firms in the open-angle glaucoma (OAG) marketplace are placing high importance on forging new, cutting-edge solutions such as minimally invasive glaucoma devices (MIGDs). The aim is to present improved and less intrusive alternatives for handling primary open-angle glaucoma, minimizing the dependence on typical treatments. MIGDs are a variety of surgical implants and methodologies conceived to decrease intraocular pressure in glaucoma sufferers through minor incisions and minor ocular tissue disturbance. For instance, iSTAR Medical, a medtech entity from Belgium, introduced MINIject in the Netherlands in December 2023. This treatment for primary open-angle glaucoma, integrated with a unique porous STAR material, enhances liquid outflow and reduces IOP. MINIject therefore marks an important advancement in glaucoma treatment, offering a safer and more efficient solution for managing this prominent cause of irreversible blindness, thereby reducing reliance on traditional treatments.

View the full report here:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

How Is the Open-Angle Glaucoma (OAG) Market Conceptually Defined?

Open-angle glaucoma (OAG) is a chronic, progressive eye condition characterized by the gradual clogging of the drainage canals in the eye, leading to increased intraocular pressure that damages the optic nerve, often without noticeable symptoms until significant vision loss occurs. Its treatment aims to lower intraocular pressure, thereby preventing optic nerve damage and preserving vision through medications, laser procedures, or surgical interventions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20911

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of theOpen-Angle Glaucoma (OAG) Market?

Increased consciousness around eye disorders is predicted to boost the progress of the open-angle glaucoma (OAG) market in the future. Eye disorders include a broad spectrum of health issues that affect the structure, function, or sight of the eyes, varying from minor problems like dry eye to grave conditions like glaucoma and macular degeneration. Factors such as aging populations, extended screen usage, rise in diabetes, environmental pollution, and lifestyle habits adversely impacting ocular health contribute to their prevalence. Open-angle glaucoma (OAG), a primary reason for blindness particularly in older populations, emphasizes the importance of regular eye checks, swift diagnosis, and preemptive treatment to prevent permanent vision damage. For example, in October 2023, the Royal National Institute of Blind People (RNIB), a sight loss charity based in the UK, stated that the number of eye care outpatient appointments in the UK in 2021/22 went beyond eight million, making it the most sought-after specialty. Moreover, the count of people suffering from sight loss, now exceeding two million, is anticipated to rise to over four million by 2050. Hence, increasing awareness about eye disorders is fueling the growth of the open-angle glaucoma (OAG) market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

#What is the Growth Potential of the Open-Angle Glaucoma (OAG) Market, and How Will It Perform by 2034?

Recent years have seen robust growth in the open-angle glaucoma (OAG) market size. Predicted to swell from $6.13 billion in 2024 to $6.55 billion in 2025, it is set to achieve a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this growth in the historic period include a heightened incidence of glaucoma amongst older populations, an increase in public awareness for early diagnosis of eye conditions, growing healthcare spending, the implementation of government-powered vision care initiatives, and the worldwide expansion of ophthalmology practices.

In the coming years, the open-angle glaucoma (OAG) market is anticipated to experience substantial growth, with a projected increase to $8.42 billion in 2029, reflecting a compound annual growth rate (CAGR) of 6.5%. The market growth during this forecast period can be credited to the escalating demand for combination treatments, an amplified focus on personalized healthcare, improvements in reimbursement policies for glaucoma procedures, an increased prevalence of ocular conditions due to lifestyle habits, and an emerging preference for non-invasive diagnostic techniques. Key trends during the forecast period are expected to include the expanding usage of AI in glaucoma diagnostics, a trend towards outpatient glaucoma surgical treatments, incremented use of sustained-release glaucoma implants, a growing incorporation of wearable technology in monitoring intraocular pressure, and an increased emphasis on sustainability in the manufacturing of medical devices.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20911

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theOpen-Angle Glaucoma (OAG) Market?

Significant market players in the open-angle glaucoma (OAG) industry are focusing more on the creation of new solutions, such as minimally invasive glaucoma devices (MIGDs), in order to offer better and less aggressive options for handling primary open-angle glaucoma. This also reduces the need for traditional treatments. These MIGDs include a variety of surgical procedures and implants, specifically developed to decrease intraocular pressure in glaucoma patients with minimal invasion and damage to eye tissues. In December 2023, for example, iSTAR Medical, a medtech firm from Belgium, introduced MINIject in the Netherlands. This innovative treatment for primary open-angle glaucoma employs a unique porous STAR material to boost fluid drainage and reduce IOP. MINIject represents an important shift in glaucoma care by offering a safer and more effective handling option for the primary cause of irreversible blindness. This also allows for a reduced reliance on the standard treatment methods.

Who Are the Key Market Players Influencing the Growth of the Corn and Open-Angle Glaucoma (OAG) Industry?

Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Which Key Market Segments Comprise the Open-Angle Glaucoma (OAG) Market and Drive Its Revenue Growth?

The open-angle glaucoma (OAG) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

Which Regions Are Emerging as Leaders in the Open-Angle Glaucoma (OAG) Market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2025, By The Business Research Company:

Antiglaucoma Drugs Global Market Report 2025

https://thebusinessresearchcompany.com/report/antiglaucoma-drugs-global-market-report

Glaucoma Surgery Devices Global Market Report 2025

https://thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report

Myopia and Presbyopia Treatment Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/myopia-and-presbyopia-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the open-angle glaucoma (oag) market right now?

The market for open-angle glaucoma (OAG) has seen significant growth recently, and is set to increase from $6.13 billion in 2024 to $6.55 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The past period of growth can be ascribed to several factors including a higher incidence of glaucoma among the older demographic, heightened consciousness about the early diagnosis of eye conditions, increased healthcare spending, governmental strategies for eye care programs, and a global proliferation of ophthalmology practices.

How fast Is the open-angle glaucoma (oag) market expected to grow, and what’s its future value?

In the coming years, a substantial growth is expected in the open-angle glaucoma (OAG) market. The market is projected to reach $8.42 billion by 2029 with a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth over the forecast period include a rising demand for combination therapies, increased attention to personalized medicine, better reimbursement schemes for glaucoma treatments, an uptick in lifestyle-related eye conditions, and an escalating need for non-invasive diagnostic procedures. Significant trends during the forecast period comprise a wider acceptance of AI in glaucoma diagnostics, a move towards outpatient glaucoma surgical treatments, enhanced usage of prolonged-release glaucoma implants, increased combining of wearable technology for intraocular pressure monitoring, and an elevated emphasis on sustainable practices in medical device production.

Get your open-angle glaucoma (oag) market report here!

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

What are the leading drivers of growth in the open-angle glaucoma (oag) market?

Increasing consciousness about eye diseases is predicted to drive the expansion of the open-angle glaucoma (OAG) market in the future. Eye disorders include various medical issues that affect the structure, functioning, or sight of the eyes, spanning from minor problems like dry eye to severe illnesses like glaucoma and macular degeneration. There is an increase in their occurrence owing to aging demographics, extensive screen time, rising instances of diabetes, environmental pollution, and lifestyle practices that exert pressure on eye health. Open-angle glaucoma (OAG), a primary source of blindness, particularly in the elderly, emphasizes the dire need for regular eye check-ups, early detection, and preemptive treatment to prevent permanent vision impairment. For example, the Royal National Institute of Blind People (RNIB), a vision loss charity based in the UK, reported in October 2023 that eye care outpatient visits in the UK had crossed eight million in 2021/22, rendering it the most sought-after specialty. Moreover, the count of people with vision loss, already exceeding two million, is estimated to jump to over four million by 2050. Thus, the increasing consciousness regarding eye diseases is stimulating the growth of the open-angle glaucoma (OAG) market.

What are the key segments defining the open-angle glaucoma (oag) market?

The open-angle glaucoma (OAG) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

Who are the key players steering the development of the open-angle glaucoma (oag) market?

Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals

What are the key trends shaping the future of the open-angle glaucoma (oag) market?

Major companies operating in the open-angle glaucoma (OAG) market are prioritizing the development of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to provide advanced and less invasive alternatives for managing primary open-angle glaucoma while reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) refers to a range of surgical implants and techniques designed to lower intraocular pressure in glaucoma patients through small incisions and minimal disruption of ocular tissues. For instance, in December 2023, iSTAR Medical, a Belgium-based medtech company, launched MINIject in the Netherlands. This bio-integrating treatment for primary open-angle glaucoma utilizes a unique porous STAR material to enhance fluid outflow and reduce IOP. By decreasing dependency on conventional therapies, MINIject represents a significant breakthrough in glaucoma care, offering a safer and more effective management option for this leading cause of permanent blindness.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20911

Which regions are most influential in expanding the open-angle glaucoma (oag) market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Antiglaucoma Drugs Global Market Report 2025

https://thebusinessresearchcompany.com/report/antiglaucoma-drugs-global-market-report

Glaucoma Surgery Devices Global Market Report 2025

https://thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report

Myopia and Presbyopia Treatment Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/myopia-and-presbyopia-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: